PLoS ONE · 2013 · 338 citations · 44 references
GeneticsGenetic EpidemiologyAd MarkersGenome-wide Association StudiesGeriatric NeurologyGenome-wide Association StudyAlzheimer's DiseaseGenotype-phenotype AssociationBiostatisticsNeurologyAging-associated DiseasePublic HealthStatistical GeneticsGenetic FactorMissing HeritabilityNeurodegenerationImaging GenomicsNeurodegenerative DiseasesCommon SnpsDementiaNeuroscienceMedicineDisease Genetics Consortium
Alzheimer's disease (AD) is a complex disorder influenced by environmental and genetic factors. Recent work has identified 11 AD markers in 10 loci. We used Genome-wide Complex Trait Analysis to analyze >2 million SNPs for 10,922 individuals from the Alzheimer's Disease Genetics Consortium to assess the phenotypic variance explained first by known late-onset AD loci, and then by all SNPs in the Alzheimer's Disease Genetics Consortium dataset. In all, 33% of total phenotypic variance is explained by all common SNPs. APOE alone explained 6% and other known markers 2%, meaning more than 25% of phenotypic variance remains unexplained by known markers, but is tagged by common SNPs included on genotyping arrays or imputed with HapMap genotypes. Novel AD markers that explain large amounts of phenotypic variance are likely to be rare and unidentifiable using genome-wide association studies. Based on our findings and the current direction of human genetics research, we suggest specific study designs for future studies to identify the remaining heritability of Alzheimer's disease.
44
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
Shaun Purcell, Benjamin M. Neale, Katherine EO Todd-Brown et al. · The American Journal of Human Genetics · 2007 · 34.9K citations · Full text
Genome-wide Association Study, Whole-genome Association, Linkage Disequilibrium +12
The International HapMap Project